Atlas Trials

Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia

Clinical trial NCT04355026 · UNKNOWN

Trial details

NCT number
NCT04355026
Sponsor
General and Teaching Hospital Celje
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Covid-19
Start date
2020-04-10
Primary completion
2020-06-30
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.